-
1
-
-
79961060508
-
-
World Health Organization, Accessed 1 June 2015
-
World Health Organization. Global status report on noncommunicable diseases. 2014. http://www.who.int. Accessed 1 June 2015.
-
(2014)
Global status report on noncommunicable diseases
-
-
-
2
-
-
47849094335
-
Hyperlipidemia in the elderly
-
PID: 18672183, (vi)
-
Ducharme N, Radhamma R. Hyperlipidemia in the elderly. Clin Geriatr Med. 2008;24(3):471–87 (vi).
-
(2008)
Clin Geriatr Med
, vol.24
, Issue.3
, pp. 471-487
-
-
Ducharme, N.1
Radhamma, R.2
-
3
-
-
85056193587
-
Health survey for England 2013: the use of prescribed medicines
-
Chaplin S. Health survey for England 2013: the use of prescribed medicines. Prescriber. 2015;26(4):16–9.
-
(2015)
Prescriber
, vol.26
, Issue.4
, pp. 16-19
-
-
Chaplin, S.1
-
4
-
-
84928815282
-
Kit BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012
-
Hyattsville: National Center for Health Statistics
-
Gu QP, Paulose-Ram R, Burt VL, Kit BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012. NCHS data brief, no 177. Hyattsville: National Center for Health Statistics; 2014. http://www.cdc.gov/nchs/data/databriefs/db177.pdf. Accessed 1 June 2015.
-
(2014)
NCHS data brief
, vol.177
-
-
Gu, Q.P.1
Paulose-Ram, R.2
Burt, V.L.3
-
5
-
-
84880271369
-
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
-
PID: 23447425
-
Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 2013;20(4):641–57.
-
(2013)
Eur J Prev Cardiol
, vol.20
, Issue.4
, pp. 641-657
-
-
Naci, H.1
Brugts, J.J.2
Fleurence, R.3
Tsoi, B.4
Toor, H.5
Ades, A.E.6
-
6
-
-
70350426230
-
Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma
-
PID: 19807799, (author reply 3–4)
-
Aronow WS. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma. J Am Geriatr Soc. 2009;57(10):1942–3 (author reply 3–4).
-
(2009)
J Am Geriatr Soc
, vol.57
, Issue.10
, pp. 1942-1943
-
-
Aronow, W.S.1
-
7
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
COI: 1:CAS:528:DC%2BD2MXhtVOlu7fM, PID: 16214597
-
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–78.
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
-
8
-
-
67650094615
-
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
-
COI: 1:STN:280:DC%2BD1Mvls1CltQ%3D%3D, PID: 19567909
-
Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 2009;338:b2376.
-
(2009)
BMJ
, vol.338
, pp. b2376
-
-
Brugts, J.J.1
Yetgin, T.2
Hoeks, S.E.3
Gotto, A.M.4
Shepherd, J.5
Westendorp, R.G.6
-
9
-
-
84874812584
-
Statins for the primary prevention of cardiovascular disease
-
PID: 23440795
-
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.
-
(2013)
Cochrane Database Syst Rev.
, vol.1
, pp. CD004816
-
-
Taylor, F.1
Huffman, M.D.2
Macedo, A.F.3
Moore, T.H.4
Burke, M.5
Davey Smith, G.6
-
10
-
-
84883337835
-
Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks
-
PID: 23928920
-
Minder CM, Blumenthal RS, Blaha MJ. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks. Curr Opin Cardiol. 2013;28(5):554–60.
-
(2013)
Curr Opin Cardiol
, vol.28
, Issue.5
, pp. 554-560
-
-
Minder, C.M.1
Blumenthal, R.S.2
Blaha, M.J.3
-
11
-
-
84902576469
-
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
PID: 24239923
-
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2889-2934
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
Bairey Merz, C.N.4
Blum, C.B.5
Eckel, R.H.6
-
12
-
-
84868207719
-
Appropriateness of statins in patients aged ≥80 years and comparison to other age groups
-
COI: 1:CAS:528:DC%2BC38Xht1aksbnL, PID: 22901970
-
Chokshi NP, Messerli FH, Sutin D, Supariwala AA, Shah NR. Appropriateness of statins in patients aged ≥80 years and comparison to other age groups. Am J Cardiol. 2012;110(10):1477–81.
-
(2012)
Am J Cardiol
, vol.110
, Issue.10
, pp. 1477-1481
-
-
Chokshi, N.P.1
Messerli, F.H.2
Sutin, D.3
Supariwala, A.A.4
Shah, N.R.5
-
13
-
-
84920593746
-
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort
-
PID: 25401375
-
Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, et al. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA Intern Med. 2015;175(1):138–40.
-
(2015)
JAMA Intern Med
, vol.175
, Issue.1
, pp. 138-140
-
-
Miedema, M.D.1
Lopez, F.L.2
Blaha, M.J.3
Virani, S.S.4
Coresh, J.5
Ballantyne, C.M.6
-
14
-
-
24144491637
-
Approaches to appropriate drug prescribing for the older adult
-
PID: 16140126
-
Petrone K, Katz P. Approaches to appropriate drug prescribing for the older adult. Prim Care. 2005;32(3):755–75.
-
(2005)
Prim Care
, vol.32
, Issue.3
, pp. 755-775
-
-
Petrone, K.1
Katz, P.2
-
15
-
-
1242306685
-
Adverse drug reactions in elderly patients
-
COI: 1:STN:280:DC%2BD2c%2FkvVWmsQ%3D%3D, PID: 14748810
-
Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6.
-
(2004)
Br J Clin Pharmacol
, vol.57
, Issue.2
, pp. 121-126
-
-
Routledge, P.A.1
O’Mahony, M.S.2
Woodhouse, K.W.3
-
16
-
-
79957536981
-
Geriatric drug evaluation: where are we now and where should we be in the future?
-
PID: 21606098
-
Cho S, Lau SW, Tandon V, Kumi K, Pfuma E, Abernethy DR. Geriatric drug evaluation: where are we now and where should we be in the future? Arch Intern Med. 2011;171(10):937–40.
-
(2011)
Arch Intern Med
, vol.171
, Issue.10
, pp. 937-940
-
-
Cho, S.1
Lau, S.W.2
Tandon, V.3
Kumi, K.4
Pfuma, E.5
Abernethy, D.R.6
-
17
-
-
0027167905
-
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data
-
COI: 1:STN:280:DyaK3s3ktlyntQ%3D%3D, PID: 8481074
-
Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med. 1993;153(9):1065–73.
-
(1993)
Arch Intern Med
, vol.153
, Issue.9
, pp. 1065-1073
-
-
Kronmal, R.A.1
Cain, K.C.2
Ye, Z.3
Omenn, G.S.4
-
18
-
-
84928109687
-
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States
-
PID: 25894023
-
Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015;162(8):533–41.
-
(2015)
Ann Intern Med
, vol.162
, Issue.8
, pp. 533-541
-
-
Odden, M.C.1
Pletcher, M.J.2
Coxson, P.G.3
Thekkethala, D.4
Guzman, D.5
Heller, D.6
-
19
-
-
84872011968
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
-
PID: 19631507
-
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.
-
(2009)
J Clin Epidemiol
, vol.62
, Issue.10
, pp. e1-e34
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
Mulrow, C.4
Gotzsche, P.C.5
Ioannidis, J.P.6
-
20
-
-
85018142475
-
AHRQ publication no
-
Eder M, Feightner A, Webber E, Guirguis-Blake J, Whitlock E. Developing and selecting topic nominations for systematic reviews. Methods guide for comparative effectiveness reviews. Agency for Healthcare Research and Quality. November 2012. AHRQ publication no. 12(13)-EHC153-EF. http://www.effectivehealthcare.ahrq.gov/. Accessed 1 Aug 2014.
-
(2012)
12(13)-EHC153-EF
-
-
Eder, M.1
Feightner, A.2
Webber, E.3
Guirguis-Blake, J.4
Developing, W.E.5
-
21
-
-
85100415918
-
Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions
-
Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. http://handbook.cochrane.org/. Accessed 1 Aug 2014.
-
(2011)
Version 5.1.0 [updated]
-
-
Higgins, J.P.T.1
-
22
-
-
70849095713
-
Relationship between non-specific prescription pill adherence and ischemic stroke outcomes
-
PID: 19955739
-
Ovbiagele B, Campbell S, Faiz A, Chambless LE. Relationship between non-specific prescription pill adherence and ischemic stroke outcomes. Cerebrovasc Dis. 2010;29(2):146–53.
-
(2010)
Cerebrovasc Dis
, vol.29
, Issue.2
, pp. 146-153
-
-
Ovbiagele, B.1
Campbell, S.2
Faiz, A.3
Chambless, L.E.4
-
23
-
-
84859001212
-
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
-
PID: 22008217
-
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
-
(2011)
BMJ
, vol.343
, pp. d5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
Juni, P.4
Moher, D.5
Oxman, A.D.6
-
24
-
-
84857064061
-
Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis
-
COI: 1:CAS:528:DC%2BC38Xlslygurs%3D, PID: 22187291
-
Chen YH, Feng B, Chen ZW. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes. 2012;120(2):116–20.
-
(2012)
Exp Clin Endocrinol Diabetes
, vol.120
, Issue.2
, pp. 116-120
-
-
Chen, Y.H.1
Feng, B.2
Chen, Z.W.3
-
25
-
-
84871202527
-
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis
-
PID: 23186103
-
de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012;72(18):2365–73.
-
(2012)
Drugs
, vol.72
, Issue.18
, pp. 2365-2373
-
-
de Vries, F.M.1
Denig, P.2
Pouwels, K.B.3
Postma, M.J.4
Hak, E.5
-
26
-
-
84864832599
-
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
-
Collaborators Cholesterol Treatment Trialists, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.
-
(2012)
Lancet
, vol.380
, Issue.9841
, pp. 581-590
-
-
Collaborators, C.T.T.1
Mihaylova, B.2
Emberson, J.3
Blackwell, L.4
Keech, A.5
Simes, J.6
-
27
-
-
77954179995
-
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants
-
COI: 1:CAS:528:DC%2BC3cXptl2ksbY%3D, PID: 20585067
-
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170(12):1024–31.
-
(2010)
Arch Intern Med
, vol.170
, Issue.12
, pp. 1024-1031
-
-
Ray, K.K.1
Seshasai, S.R.2
Erqou, S.3
Sever, P.4
Jukema, J.W.5
Ford, I.6
-
28
-
-
81055137319
-
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
-
PID: 21989464
-
Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ. 2011;183(16):E1189–202.
-
(2011)
CMAJ
, vol.183
, Issue.16
, pp. E1189-E1202
-
-
Tonelli, M.1
Lloyd, A.2
Clement, F.3
Conly, J.4
Husereau, D.5
Hemmelgarn, B.6
-
29
-
-
64349105221
-
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
-
COI: 1:CAS:528:DC%2BD1MXlsVajsb8%3D, PID: 19375663
-
Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453–63.
-
(2009)
Lancet Neurol
, vol.8
, Issue.5
, pp. 453-463
-
-
Amarenco, P.1
Labreuche, J.2
-
30
-
-
78751680407
-
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials
-
COI: 1:STN:280:DC%2BC3M7isFGrsQ%3D%3D, PID: 20934984
-
Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104(2):109–24.
-
(2011)
QJM
, vol.104
, Issue.2
, pp. 109-124
-
-
Mills, E.J.1
Wu, P.2
Chong, G.3
Ghement, I.4
Singh, S.5
Akl, E.A.6
-
31
-
-
84875586767
-
Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials
-
COI: 1:CAS:528:DC%2BC3sXhvVyksb3K, PID: 23431221
-
Naci H, Brugts JJ, Fleurence R, Ades AE. Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials. QJM. 2013;106(4):299–306.
-
(2013)
QJM.
, vol.106
, Issue.4
, pp. 299-306
-
-
Naci, H.1
Brugts, J.J.2
Fleurence, R.3
Ades, A.E.4
-
32
-
-
84878012897
-
Impact of statin dose on major cardiovascular events: a mixed treatment comparison meta-analysis involving more than 175,000 patients
-
PID: 22192281
-
Ribeiro RA, Ziegelmann PK, Duncan BB, Stella SF, da Costa Vieira JL, Restelatto LM, et al. Impact of statin dose on major cardiovascular events: a mixed treatment comparison meta-analysis involving more than 175,000 patients. Int J Cardiol. 2013;166(2):431–9.
-
(2013)
Int J Cardiol
, vol.166
, Issue.2
, pp. 431-439
-
-
Ribeiro, R.A.1
Ziegelmann, P.K.2
Duncan, B.B.3
Stella, S.F.4
da Costa Vieira, J.L.5
Restelatto, L.M.6
-
33
-
-
0037132607
-
Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative. Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288(23):2998–3007.
-
(2002)
JAMA
, vol.288
, Issue.23
, pp. 2998-3007
-
-
-
34
-
-
79951676299
-
Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm
-
COI: 1:CAS:528:DC%2BC3MXhvVykurw%3D, PID: 21297502
-
Collier DJ, Poulter NR, Dahlof B, Sever PS, Wedel H, Buch J, et al. Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm. J Hypertens. 2011;29(3):592–9.
-
(2011)
J Hypertens
, vol.29
, Issue.3
, pp. 592-599
-
-
Collier, D.J.1
Poulter, N.R.2
Dahlof, B.3
Sever, P.S.4
Wedel, H.5
Buch, J.6
-
35
-
-
0141920715
-
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients
-
PID: 12888702
-
Bruckert E, Lievre M, Giral P, Crepaldi G, Masana L, Vrolix M, et al. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients. Am J Geriatr Cardiol. 2003;12(4):225–31.
-
(2003)
Am J Geriatr Cardiol
, vol.12
, Issue.4
, pp. 225-231
-
-
Bruckert, E.1
Lievre, M.2
Giral, P.3
Crepaldi, G.4
Masana, L.5
Vrolix, M.6
-
36
-
-
33845493715
-
Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)
-
COI: 1:CAS:528:DC%2BD28Xht1GktbbJ, PID: 17065671
-
Neil HA, DeMicco DA, Luo D, Betteridge DJ, Colhoun HM, Durrington PN, et al. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care. 2006;29(11):2378–84.
-
(2006)
Diabetes Care
, vol.29
, Issue.11
, pp. 2378-2384
-
-
Neil, H.A.1
DeMicco, D.A.2
Luo, D.3
Betteridge, D.J.4
Colhoun, H.M.5
Durrington, P.N.6
-
37
-
-
0037840242
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
-
PID: 12814710
-
Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361(9374):2005–16.
-
(2003)
Lancet
, vol.361
, Issue.9374
, pp. 2005-2016
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleigh, P.4
Peto, R.5
-
38
-
-
77953006109
-
Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial
-
PID: 20404379, (W174)
-
Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152(8):488–96 (W174).
-
(2010)
Ann Intern Med.
, vol.152
, Issue.8
, pp. 488-496
-
-
Glynn, R.J.1
Koenig, W.2
Nordestgaard, B.G.3
Shepherd, J.4
Ridker, P.M.5
-
39
-
-
80052851569
-
Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study)
-
COI: 1:CAS:528:DC%2BC3MXhsVOjsbbP, PID: 21815708
-
Nakaya N, Mizuno K, Ohashi Y, Teramoto T, Yokoyama S, Hirahara K, et al. Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Drugs Aging. 2011;28(9):681–92.
-
(2011)
Drugs Aging
, vol.28
, Issue.9
, pp. 681-692
-
-
Nakaya, N.1
Mizuno, K.2
Ohashi, Y.3
Teramoto, T.4
Yokoyama, S.5
Hirahara, K.6
-
40
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
-
COI: 1:CAS:528:DC%2BD38XovFegt7o%3D, PID: 12457784
-
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30.
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.4
Buckley, B.M.5
Cobbe, S.M.6
-
41
-
-
84888357522
-
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis
-
COI: 1:CAS:528:DC%2BC3sXhvFWjtrvK, PID: 23954343
-
Savarese G, Gotto AM Jr, Paolillo S, D’Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013;62(22):2090–9.
-
(2013)
J Am Coll Cardiol
, vol.62
, Issue.22
, pp. 2090-2099
-
-
Savarese, G.1
Gotto, A.M.2
Paolillo, S.3
D’Amore, C.4
Losco, T.5
Musella, F.6
-
42
-
-
24344466285
-
Lipid lowering and recurrent stroke: another stroke paradox?
-
PID: 16087646
-
Amarenco P. Lipid lowering and recurrent stroke: another stroke paradox? Eur Heart J. 2005;26(18):1818–9.
-
(2005)
Eur Heart J
, vol.26
, Issue.18
, pp. 1818-1819
-
-
Amarenco, P.1
-
43
-
-
33645881669
-
Statin safety: a systematic review
-
COI: 1:CAS:528:DC%2BD28XkvF2gsr4%3D, PID: 16581329
-
Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006;97(8A):52C–60C.
-
(2006)
Am J Cardiol
, vol.97
, Issue.8A
, pp. 52C-60C
-
-
Law, M.1
Rudnicka, A.R.2
-
44
-
-
79959428660
-
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
-
COI: 1:CAS:528:DC%2BC3MXotVantLs%3D, PID: 21693744
-
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305(24):2556–64.
-
(2011)
JAMA
, vol.305
, Issue.24
, pp. 2556-2564
-
-
Preiss, D.1
Seshasai, S.R.2
Welsh, P.3
Murphy, S.A.4
Ho, J.E.5
Waters, D.D.6
-
45
-
-
2942705774
-
Safety of statins: focus on clinical pharmacokinetics and drug interactions
-
PID: 15198967
-
Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004;109(23 Suppl 1):III50–7.
-
(2004)
Circulation
, vol.109
, pp. III50-III57
-
-
Bellosta, S.1
Paoletti, R.2
Corsini, A.3
-
46
-
-
0032805692
-
New insights into the pharmacodynamic and pharmacokinetic properties of statins
-
COI: 1:CAS:528:DyaK1MXnslGqs78%3D, PID: 10665838
-
Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther. 1999;84(3):413–28.
-
(1999)
Pharmacol Ther
, vol.84
, Issue.3
, pp. 413-428
-
-
Corsini, A.1
Bellosta, S.2
Baetta, R.3
Fumagalli, R.4
Paoletti, R.5
Bernini, F.6
-
47
-
-
77549087054
-
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
-
COI: 1:CAS:528:DC%2BC3cXisFart74%3D, PID: 20167359
-
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735–42.
-
(2010)
Lancet
, vol.375
, Issue.9716
, pp. 735-742
-
-
Sattar, N.1
Preiss, D.2
Murray, H.M.3
Welsh, P.4
Buckley, B.M.5
de Craen, A.J.6
-
48
-
-
84904161994
-
-
US FDA. Accessed 1 June 2015
-
US FDA. FDA expands advice on statin risks. 2014. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm. Accessed 1 June 2015.
-
(2014)
FDA expands advice on statin risks
-
-
-
49
-
-
84928679167
-
Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials
-
PID: 25575908
-
Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, et al. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med. 2015;30(3):348–58.
-
(2015)
J Gen Intern Med
, vol.30
, Issue.3
, pp. 348-358
-
-
Ott, B.R.1
Daiello, L.A.2
Dahabreh, I.J.3
Springate, B.A.4
Bixby, K.5
Murali, M.6
|